ABOUT
Company
A company dedicated to fostering the health and wellness of its customers.
I extend my sincere gratitude to the customers of Kolon Pharma for their unwavering support and trust.
In our fast-evolving pharmaceutical world, Kolon Pharma is relentlessly working to become a beacon of trust. We uphold the values of transparency and ethical management. Our primary focus lies in crafting innovative products and pioneering healthcare solutions, driving our vision for future growth. Our commitment to delivering high-quality products remains steadfast, and we take pride in the milestones we continue to achieve.
While our ambition is rooted in local leadership, our vision reaches further. We aim to be not only a cherished local pharmaceutical entity but also a formidable contender on the global pharmaceutical stage.
Your continued support is invaluable to us. From the depths of our hearts, we wish you and your family continued health and properity.
C.E.O JaeKwang Chun
My vision is to elevate KPC as a globally renowned pharmaceutical company specializing in new drug development, leveraging my extensive experience and capabilities.
Hello, I am SunJin, the CEO of Kolon Pharma’s New Drug Development Division. Inspired by my direct involvement in new drug development in the U.S., I founded Platbio, Inc. in 2018. My ambition was to navigate the intricacies of the South Korean bio-industry and lead in the development of first-in-class drugs.
After marking several significant accomplishments, the merger with KPC became a strategic step to bring my vision closer to fruition.
This amalgamation of Platbio’s innovative drug development expertise and KPC’s robust business infrastructure positions us on the threshold of becoming a global leader in new drug development.
Our ambition is not limited to Korea. We are setting our sights on the international stage, striving to set benchmarks in new drug development through global standards and insights.
I firmly believe that if we stay committed to our core values and mission, success in novel drug development is within reach. With KPC’s elite research team, we envision Korea leading the charge in the global pharmaceutical domain.
Challenges are an integral part of our journey, but I humbly request your unwavering support for KPC as we embark on this transformative journey.
Thank you.
New Drug Development Division C.E.O SunJin Kim
